Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soybean Oil | 4 | 2023 | 139 | 0.950 |
Why?
|
Fat Emulsions, Intravenous | 6 | 2023 | 314 | 0.720 |
Why?
|
Fatty Liver | 3 | 2023 | 810 | 0.690 |
Why?
|
Fish Oils | 6 | 2023 | 483 | 0.590 |
Why?
|
Parenteral Nutrition | 6 | 2023 | 663 | 0.540 |
Why?
|
alpha-Tocopherol | 2 | 2019 | 127 | 0.310 |
Why?
|
Protective Agents | 2 | 2019 | 150 | 0.300 |
Why?
|
Intestinal Diseases | 2 | 2022 | 505 | 0.280 |
Why?
|
Triglycerides | 3 | 2023 | 2464 | 0.240 |
Why?
|
Heparin | 2 | 2022 | 1636 | 0.230 |
Why?
|
Emulsions | 1 | 2023 | 152 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2022 | 3518 | 0.200 |
Why?
|
Liver Diseases | 2 | 2022 | 1305 | 0.200 |
Why?
|
Carbohydrates | 1 | 2023 | 389 | 0.190 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2019 | 1248 | 0.190 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2019 | 1399 | 0.180 |
Why?
|
Liver Failure | 1 | 2022 | 252 | 0.180 |
Why?
|
Cholestasis | 1 | 2022 | 385 | 0.160 |
Why?
|
Lung | 5 | 2022 | 10097 | 0.160 |
Why?
|
Pneumonectomy | 4 | 2021 | 1159 | 0.160 |
Why?
|
Isoquinolines | 1 | 2020 | 354 | 0.160 |
Why?
|
Fatty Acids | 2 | 2023 | 1812 | 0.160 |
Why?
|
Endotoxemia | 1 | 2019 | 198 | 0.150 |
Why?
|
Deficiency Diseases | 1 | 2017 | 74 | 0.140 |
Why?
|
Infant Nutrition Disorders | 1 | 2017 | 70 | 0.140 |
Why?
|
Catheter-Related Infections | 1 | 2020 | 275 | 0.140 |
Why?
|
Glycine | 1 | 2020 | 672 | 0.140 |
Why?
|
Child Nutrition Disorders | 1 | 2017 | 140 | 0.130 |
Why?
|
PPAR gamma | 1 | 2019 | 487 | 0.130 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2017 | 294 | 0.130 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 536 | 0.120 |
Why?
|
Micronutrients | 1 | 2017 | 390 | 0.120 |
Why?
|
Vehicle Emissions | 1 | 2019 | 651 | 0.120 |
Why?
|
Liver | 4 | 2023 | 7579 | 0.110 |
Why?
|
Pericytes | 1 | 2016 | 299 | 0.110 |
Why?
|
Mice, Inbred C57BL | 9 | 2022 | 22381 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18366 | 0.100 |
Why?
|
Reperfusion Injury | 1 | 2019 | 1036 | 0.100 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2022 | 1459 | 0.100 |
Why?
|
Models, Biological | 2 | 2020 | 9499 | 0.100 |
Why?
|
Receptors, Notch | 1 | 2016 | 751 | 0.090 |
Why?
|
Models, Animal | 1 | 2017 | 2123 | 0.090 |
Why?
|
Swine | 2 | 2018 | 5998 | 0.090 |
Why?
|
Mice | 9 | 2023 | 82074 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1813 | 0.080 |
Why?
|
Animals | 14 | 2023 | 169408 | 0.080 |
Why?
|
Nutritional Status | 1 | 2017 | 1627 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1045 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 1371 | 0.080 |
Why?
|
Cell Communication | 1 | 2016 | 1660 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2022 | 3982 | 0.080 |
Why?
|
Particulate Matter | 1 | 2019 | 2607 | 0.070 |
Why?
|
Air Pollutants | 1 | 2019 | 2905 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6434 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2754 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2017 | 3442 | 0.060 |
Why?
|
Endothelial Cells | 3 | 2022 | 3591 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2019 | 4538 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5892 | 0.060 |
Why?
|
Inflammation | 2 | 2019 | 10869 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7472 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5800 | 0.050 |
Why?
|
Compliance | 1 | 2020 | 100 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2022 | 344 | 0.040 |
Why?
|
Picolinic Acids | 1 | 2020 | 50 | 0.040 |
Why?
|
Total Lung Capacity | 1 | 2020 | 149 | 0.040 |
Why?
|
Hematocrit | 1 | 2021 | 623 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 374 | 0.040 |
Why?
|
Phytosterols | 1 | 2019 | 55 | 0.040 |
Why?
|
Interleukin-6 | 2 | 2019 | 3233 | 0.040 |
Why?
|
United States Environmental Protection Agency | 1 | 2019 | 139 | 0.040 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2019 | 103 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 84 | 0.040 |
Why?
|
Serpins | 1 | 2020 | 246 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 436 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 4356 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 550 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2020 | 665 | 0.040 |
Why?
|
Male | 8 | 2023 | 365249 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2020 | 564 | 0.040 |
Why?
|
Eye Proteins | 1 | 2020 | 628 | 0.030 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 363 | 0.030 |
Why?
|
Microcirculation | 1 | 2021 | 1281 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2019 | 606 | 0.030 |
Why?
|
Drug Design | 1 | 2021 | 1046 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 808 | 0.030 |
Why?
|
Signal Transduction | 4 | 2021 | 23652 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 1695 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2268 | 0.030 |
Why?
|
Biometry | 1 | 2018 | 570 | 0.030 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2017 | 352 | 0.030 |
Why?
|
Necrosis | 1 | 2019 | 1621 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2021 | 10486 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2017 | 740 | 0.030 |
Why?
|
Infant | 3 | 2022 | 36541 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1904 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2019 | 14485 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15662 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1339 | 0.030 |
Why?
|
Exercise Test | 1 | 2021 | 2187 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2695 | 0.030 |
Why?
|
Cell Polarity | 1 | 2016 | 639 | 0.030 |
Why?
|
Humans | 9 | 2023 | 768887 | 0.030 |
Why?
|
Eicosapentaenoic Acid | 1 | 2016 | 565 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1342 | 0.020 |
Why?
|
Hepatocytes | 1 | 2019 | 1246 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2222 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1608 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2016 | 840 | 0.020 |
Why?
|
Spleen | 1 | 2016 | 2294 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2022 | 26394 | 0.020 |
Why?
|
Docosahexaenoic Acids | 1 | 2016 | 914 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8317 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6512 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3858 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10778 | 0.020 |
Why?
|
Child | 3 | 2022 | 80969 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1890 | 0.020 |
Why?
|
Escherichia coli | 1 | 2019 | 4212 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4850 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6525 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42684 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23847 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5794 | 0.020 |
Why?
|
Incidence | 1 | 2022 | 21545 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81892 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2022 | 65485 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74971 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22294 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15603 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15471 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15889 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13087 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40266 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2022 | 59738 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41800 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54950 | 0.010 |
Why?
|
Female | 3 | 2020 | 397464 | 0.010 |
Why?
|
United States | 1 | 2019 | 73180 | 0.010 |
Why?
|
Aged | 1 | 2022 | 171790 | 0.010 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_